Results

Total Results: 4,630 records

Showing results for "tissue".

  1. www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0197-fullreport.pdf
    November 01, 2019 - radiation dose for pediatric patients is highly problematic because the developing cellular structures and tissues
  2. www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0197-fullreport.pdf
    November 01, 2019 - radiation dose for pediatric patients is highly problematic because the developing cellular structures and tissues
  3. www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0197-fullreport.pdf
    November 01, 2019 - radiation dose for pediatric patients is highly problematic because the developing cellular structures and tissues
  4. www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-196-fullreport.pdf
    January 01, 2020 - radiation dose for pediatric patients is highly problematic because developing cellular structures and tissues
  5. www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0197-fullreport.pdf
    November 01, 2019 - radiation dose for pediatric patients is highly problematic because the developing cellular structures and tissues
  6. www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-196-fullreport.pdf
    January 01, 2020 - radiation dose for pediatric patients is highly problematic because developing cellular structures and tissues
  7. www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0197-fullreport.pdf
    November 01, 2019 - radiation dose for pediatric patients is highly problematic because the developing cellular structures and tissues
  8. www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-196-fullreport.pdf
    January 01, 2020 - radiation dose for pediatric patients is highly problematic because developing cellular structures and tissues
  9. ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-196-fullreport.pdf
    January 01, 2020 - radiation dose for pediatric patients is highly problematic because developing cellular structures and tissues
  10. ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0197-fullreport.pdf
    November 01, 2019 - radiation dose for pediatric patients is highly problematic because the developing cellular structures and tissues
  11. effectivehealthcare.ahrq.gov/sites/default/files/pdf/plant-based-chronic-pain-review-q3.pdf
    September 01, 2021 - Background Chronic pain is defined as pain lasting longer than 3 to 6 months or past normal time for tissue … women) 18 years and older with chronic pain (>12 weeks or pain persisting past the time for normal tissue
  12. effectivehealthcare.ahrq.gov/sites/default/files/pdf/vitamin-d-calcium_executive.pdf
    September 01, 2014 - cancer, immune function, pregnancy or birth outcomes, mortality, fracture, renal outcomes, and soft tissue … tolerable upper intake levels, such as all-cause mortality, cancer (incidence and mortality), soft tissue
  13. www.uspreventiveservicestaskforce.org/home/getfilebytoken/ghTxWfpzXrJRXU8SZECvsk
    August 01, 2022 - 15,165 #20 #19 NOT (([animal cell]/lim OR [animal experiment]/lim OR [animal model]/lim OR [animal tissue … ) 6,423 #9 #8 NOT (([animal cell]/lim OR [animal experiment]/lim OR [animal model]/lim OR [animal tissue
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/vitamin-d-calcium_executive.pdf
    September 01, 2014 - cancer, immune function, pregnancy or birth outcomes, mortality, fracture, renal outcomes, and soft tissue … tolerable upper intake levels, such as all-cause mortality, cancer (incidence and mortality), soft tissue
  15. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/vitamin-d-calcium_executive.pdf
    September 01, 2014 - cancer, immune function, pregnancy or birth outcomes, mortality, fracture, renal outcomes, and soft tissue … tolerable upper intake levels, such as all-cause mortality, cancer (incidence and mortality), soft tissue
  16. www.uspreventiveservicestaskforce.org/home/getfilebytoken/XW6XUe2wRmkM-6Rrbn_462
    February 01, 2023 - 15,165 #20 #19 NOT (([animal cell]/lim OR [animal experiment]/lim OR [animal model]/lim OR [animal tissue … ) 6,423 #9 #8 NOT (([animal cell]/lim OR [animal experiment]/lim OR [animal model]/lim OR [animal tissue
  17. effectivehealthcare.ahrq.gov/health-topics/kidney-tests/
  18. effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/surveillance-report-2-noninvasive-nonpharma.pdf
    April 01, 2022 - chronic pain (defined as pain lasting 12 weeks or longer or pain persisting past the time for normal tissue
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/abnormal-uterine-bleeding_executive.pdf
    March 01, 2013 - thrombotic disease, risk for thrombotic disease, who smoke, are over age 35, or who concomitantly use tissue
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/surveillance-report-2-noninvasive-nonpharma.pdf
    April 01, 2022 - chronic pain (defined as pain lasting 12 weeks or longer or pain persisting past the time for normal tissue